Waters Corp
Close on Nov 20, 2026Market cap $43.27BP/E 109.8Yield –
Waters Waters Biosciences Division Revenue by Quarter
Waters Biosciences Division (WBD) Revenue (Comparable Basis) ($M)
Waters Waters Biosciences Division Revenue: $396M in Q3 2026, up 2.3% from a year earlier.
Where the Q3 2026 figure comes from
“Biosciences Division (WBD) 396 — * *”
Source: Q3 2026 Form 8-K (Item 2.02 Earnings Release) ↗
Flow cytometry instruments (FACSLyric, FACSDiscover), clinical cell analysis, and fluorochrome/antibody reagents acquired from BD in February 2026.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Waters Biosciences Division (WBD) Revenue (Comparable Basis) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 396 | +2.3% | Q3 2026 Form 8-K (Item 2.02 Earnings Release) ↗ |
| Q2 2026 | Jun 30, 2026 | 368 | +2.8% | Q2 2026 Form 8-K (Item 2.02 Earnings Release) ↗ |
| Q1 2026 | Mar 31, 2026 | 232 | +6.9% | Q1 2026 Form 8-K (Item 2.02 Earnings Release) ↗ |
| Q3 2025 | Sep 30, 2025 | 387 | – | Q3 2026 Earnings Presentation (2026-11-03), Slide 28 ↗ |
| Q2 2025 | Jun 30, 2025 | 358 | – | Q2 2026 Earnings Presentation (2026-08-04), Slide 30 ↗ |
| Q1 2025 | Mar 31, 2025 | 217 | – | Q1 2026 Earnings Presentation (2026-05-05), Slides 18 & 25-27 ↗ |
Breakdown
What makes up waters Biosciences Division Revenue
Cite this data
StockData. (2026). Waters Waters Biosciences Division Revenue ($M), quarterly Q1 2025–Q3 2026 [Data set]. Compiled from Waters SEC filings and investor materials. https://stockdatahq.com/stocks/wat/kpis/wbd-total-comp
See every metric in the Waters KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?